• Canid;
  • CSF analysis;
  • Intervertebral disk disease;
  • Spinal cord trauma


  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Footnotes
  7. Acknowledgments
  8. References

Background: Release of myelin basic protein (MBP) into the cerebrospinal fluid (CSF) is associated with active demyelination and correlates with outcome in various neurological diseases.

Hypothesis/Objectives: To describe associations among CSF MBP concentration, initial neurological dysfunction, and long-term ambulatory outcome in dogs with acute thoracolumbar intervertebral disk herniation (IVDH).

Animals: Five hundred and seventy-four dogs with acute thoracolumbar IVDH and 16 clinically normal dogs.

Methods: Prospective case series clinical study. Signalment, initial neurological dysfunction as determined by a modified Frankel score (MFS), and ambulatory outcome at >3-month follow-up were recorded. Cisternal CSF MBP concentration was determined by an ELISA. Associations were estimated between CSF MBP concentration and various clinical parameters.

Results: Dogs with thoracolumbar IVDH that did not ambulate at follow-up had a higher CSF MBP concentration (median, 3.56 ng/mL; range, 0.59–51.2 ng/mL) compared with control dogs (median, 2.22 ng/mL; range, 0–3.82 ng/mL) (P= .032). A CSF MBP concentration of ≥3 ng/mL had a sensitivity of 78% and specificity of 76% to predict an unsuccessful outcome based on receiver-operating characteristics curve analysis (area under the curve =0.688, P= .079). Affected dogs with a CSF MBP concentration ≥3 ng/mL had 0.09 times the odds of ambulation at follow-up compared with affected dogs with CSF MBP concentration <3 ng/mL when adjusted for initial MFS (95% confidence interval 0.01–0.66, P= .018).

Conclusions and Clinical Importance: These results would suggest that CSF MBP concentration may be useful as an independent prognostic indicator in dogs with thoracolumbar IVDH.


confidence interval


cerebrospinal fluid


intervertebral disk herniation


myelin basic protein


modified Frankel score


magnetic resonance imaging


receiver-operating characteristics


spinal cord injury



Intervertebral disk herniation (IVDH) is a common cause of acute spinal cord injury (SCI) in dogs, representing 2.3% of all admissions to 13 veterinary teaching hospitals.1 Disk herniation leads to SCI via a combination of primary and secondary mechanisms, which can result in spinal cord edema, demyelination, necrosis, and intraparenchymal hemorrhage.2–4 Currently, only the absence of pelvic limb deep nociception and the presence of intramedullary T2-weighted (T2W) hyperintensity on magnetic resonance imaging (MRI) are known to be strongly associated with functional outcome in dogs with thoracolumbar IVDH.5–9

Myelin basic protein (MBP) is found only in the nervous system and accounts for 30% of all myelin proteins.10,11 Various central nervous system diseases that cause demyelination can lead to release of MBP and MBP-like peptides into disrupted parenchyma and surrounding cerebrospinal fluid (CSF).11,12 For example, MBP has been detected in the CSF of humans with multiple sclerosis,13,14 traumatic brain injury,15 and optic neuritis.16 Dogs with demyelinating canine distemper17 and degenerative myelopathy18 have MBP detectable in CSF.

In SCI, MBP has been associated with neurological impairment and exacerbation of secondary mechanisms. In mouse models of contusive SCI, preservation of MBP immunostaining was correlated with functional recovery, reduced impact force, and lower MRI lesion burden.19 Also, active and passive immunization against MBP after SCI has resulted in increased lesion size and impaired functional recovery because of autoimmune destruction of white matter in a similar model.20 Transgenic mice with MBP autoreactive CD4+ T cells have also been found to have impaired locomotion after SCI compared with littermate controls.21

The prospective study reported here was designed because of the previous data indicating a relationship between MBP and lesion development after SCI as well as information supporting the release of CSF MBP in animals with naturally occurring neurological disease. We hypothesized that CSF MBP concentration in dogs with thoracolumbar IVDH would be positively associated with initial injury severity and negatively associated with long-term functional outcome.

Materials and Methods

  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Footnotes
  7. Acknowledgments
  8. References

Study Dogs

Nonambulatory dogs admitted to Texas A&M University Veterinary Medical Teaching Hospital with a history of acute-onset thoracolumbar IVDH were prospectively recruited between March 2008 and December 2008 for participation in this study and another investigation.22 Owner consent was obtained before diagnostic imaging and CSF acquisition by standard documents approved by the Clinical Research Review Committee (Protocol 08-08). Dogs had to meet the following additional criteria to be included in the affected study population: ≤7 day duration of neurologic impairment, nonambulatory paraparesis or paraplegia at initial evaluation, and extradural disk-associated spinal cord compression located between the T3-L5 vertebral articulations at surgery or necropsy.


Age, sex, breed, duration of clinical signs before admission, prereferral administration of glucocorticoids (yes/no), and prereferral administration of nonsteroidal anti-inflammatory drugs (yes/no) were recorded for all dogs. Dogs were classified as chondrodystrophoid (Dachshund [miniature and standard], Pekingese, West Highland White Terrier, Corgi, Japanese Chin, Bassett Hound, Shih Tzu, Cocker Spaniel, Lhasa Apso, Bichon Frise, and Beagle) or nonchondrodystrophoid.23–26 Neurologic dysfunction was classified at admission according to the modified Frankel score (MFS) as follows: paraspinal hyperesthesia only (grade 5), ambulatory paraparesis and ataxia (grade 4), nonambulatory paraparesis (grade 3), paraplegia with nociception (grade 2), paraplegia with no superficial nociception (grade 1), and paraplegia with no deep nociception (grade 0).27

After premedication, anesthesia was induced in all dogs with propofola (IV) and maintained on inhalant anesthetic (sevofloraneb or isofluoranec) for CSF sampling from the cerebromedullary cistern and advanced imaging. All dogs with thoracolumbar IVDH underwent advanced imaging consisting of myelography, computed tomography, or MRI. For those dogs that underwent MRI, T2W sagittal images of the vertebral column were reviewed by a board certified neurologist (J.M.L.) by a computer workstation with a 19 in. flat panel displayd and commercially available softwaree to determine if spinal cord T2W hyperintensity was present.

IVDH was confirmed at surgery (hemilaminectomy or pediculectomy) or necropsy. Routine postoperative care included opioid analgesics, bladder management, passive range of motion, and physical rehabilitation and was performed for all dogs as needed until discharge. Owners were instructed to confine their dogs for an additional 4–6 weeks after discharge and continue postoperative care as needed.

Sample Collection and Testing

Approximately 1–1.5 mL of CSF from the cerebromedullary cistern was submitted for fluid analysis to include cytology, cell counts, and protein determination in a standard red top tube. In addition, 2–4 additional aliquots (200–300 μL) of the CSF were frozen at −80°C immediately after CSF acquisition. Within 1 hour, CSF nucleated cell (NC) count, NC differential, and protein concentration were determined. Dogs in which samples had excessive blood contamination (> 13,200 RBCs/μL) were excluded from the study.28 Pleocytosis was defined as a CSF NC count ≥5 cells/μL. Type of pleocytosis was defined by >60% predominance of a particular cell type or >40% of 1 cell type with no other cell type >33%.29 The reference interval for CSF protein concentration was <27 mg/dL. Dogs without sufficient CSF for MBP determination were excluded.

CSF MBP was measured by a commercial ELISA kitf for measurement of human MBP. This assay is intended for the measurement of human MBP in CSF, and contains a goat antihuman MBP antibody. Previously published data18 have supported the detection of canine MBP by the goat antihuman MBP antibody. In-house validation of the assay in the study reported here consisted of intra- and interassay variability, dilutional parallelism, and spiking recovery. Intra-assay variability was determined using 5 replicates of 3 CSF samples, and the coefficient of variation ranged from 2.3 to 5.5%. Interassay variability was determined using 3 CSF samples, and the high and low controls provided with the assay. The interassay coefficient of variation for MBP ranged from 8 to 19.5%. The observed-to-expected ratio for CSF serial dilutions for 4 CSF samples ranged from 78.9 to 124.4% of expected. CSF containing low, medium, and high MBP concentration were obtained. The observed-to-expected ratios for combined low+medium, medium+high, and low+high pooled MBP CSF were 105.6, 91.7, and 113.7%, respectively.

Long-Term Follow-Up

All dogs with thoracolumbar IVDH that were alive were assessed for voluntary ambulation >3 months after discharge. Ambulatory status was determined via in-hospital examination or through a brief questionnaire sent to owners via electronic or regular mail. Owners that did not respond were subsequently contacted by telephone. Functional outcome was considered a success if a dog regained the ability to walk voluntarily at any point during the study. Dogs that did not recover ambulation during the follow-up period or were euthanized because of nonambulatory status were classified as unsuccessful outcomes.

Control Dogs

Normal research colony dogs (n = 16) were used as a control population after obtaining approval from the Institutional Animal Care and Use Committee (AUP 08-115). Control dogs were required to have normal physical and neurological examinations, CBC, and serum biochemistry results at the time of enrollment. CSF collection, CSF analysis, and MBP measurement were performed in the same manner as for dogs with thoracolumbar IVDH.

Statistical Analysis

Descriptive statistics were calculated for CSF MBP stratified by group (IVDH versus control), long-term success (versus not), signalment, administered treatments, and spinal cord T2W hyperintensity. Continuous variables were dichotomized based on the median and Mann-Whitney U-tests were used to compare CSF MBP concentration between groups. The correlation of CSF MBP concentration with MFS at admission, duration of injury at admission, and CSF parameters was assessed using Spearman's rho. Receiver-operating characteristics (ROC) curve analysis was performed to determine the overall effectiveness of CSF MBP concentration to predict an unsuccessful long-term outcome in dogs with confirmed thoracolumbar IVDH. The cutoff that maximized the Youden index (sensitivity+specificity−1) was selected as optimal.

Multivariable logistic regression was used to estimate the ability of CSF MBP concentration to predict a long-term successful outcome while adjusting for disease severity and other potential predictors. Quantitative variables were assessed for the assumption of being linear in the natural logarithm of the odds and those that violated this assumption were modeled as categorical variables. CSF MBP concentration was dichotomized based on the optimal cutoff identified from the ROC analysis. MFS at admission was forced into all models to adjust for disease severity. A backward stepwise approach based on Wald's tests was used to evaluate the ability of signalment and administered treatments to predict a successful outcome. Hosmer and Lemeshow tests were used to assess the fit of multivariable models. The final multivariable model was further assessed excluding noncondrodystrophic dogs to detect qualitative differences. All analyses were performed with a commercially available software packageg and evaluated at the 5% level of significance.


  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Footnotes
  7. Acknowledgments
  8. References

There were 57 dogs with thoracolumbar IVDH that met the inclusion criteria, but 3 were subsequently excluded because of insufficient CSF for MBP determination. Median age of the 54 dogs was 5 years (range, 1.5–13 years). There were 6 sexually intact females, 19 spayed females, 8 sexually intact males, and 21 castrated males. Breeds included Dachshund (miniature and standard grouped together; n = 35), mixed breed (4), Pembroke Welsh Corgi (2), Maltese (2), and 11 other breeds with 1 dog each. The majority of dogs were classified as chondrodystrophoid (50/54). The median duration of neurological signs before admission was 1 day (range, 1–7 days). The median MFS at admission was 2 (range, 0–3). Thoracolumbar IVDH was identified by MRI in 24 dogs, myelogram in 21 dogs, and CT in 9 dogs. Disk-associated compressive lesions were seen at 8 different articulations, with T13-L1 (n = 16), T12-T13 (14), and T11-T12 (10) being most common. At long-term follow-up, 42/54 dogs were voluntarily ambulatory. Of the 9 dogs with unsuccessful outcomes, 5 were euthanized before long-term follow-up with ascending-descending myelomalacia confirmed at necropsy in 3/5. Three dogs were not available for long-term follow-up.

Median age of the 16 control dogs was 3 years (range, 2–4 years). Three were spayed females and 13 were castrated males. Breeds included Labrador Retriever (n = 7), mixed breed (5), Red Bone Hound (2), and Blue Tick Hound (2). Control dogs did not have CSF pleocytosis or increased CSF protein.

In dogs with thoracolumbar IVDH, the median CSF NC count was 3 cells/μL (range, 0–245 cells/μL), the median CSF RBC count was 27 cells/μL (range, 0–10,780 cells/μL), and the median protein concentration was 28 mg/dL (range, 12–110 mg/dL). Seventeen dogs had CSF pleocytosis, which was classified as neutrophilic in 12 dogs, mixed cell in 4 dogs, and large mononuclear in 1 dog. CSF protein concentration was above the reference interval (≥ 27 mg/dL) in 28 dogs.

The CSF MBP concentration did not differ between control dogs and dogs with thoracolumbar IVDH (Table 1). Within dogs with thoracolumbar IVDH, the concentration of CSF MBP did not vary by duration of signs at admission, signalment features, corticosteroid administration, the presence of CSF pleocytosis, or T2W spinal cord hyperintensity. The CSF MBP concentration was higher in dogs with an unsuccessful long-term outcome (median, 3.56 ng/mL) compared with those with a successful outcome (median, 1.53 ng/mL), but this difference was not significant (P= .081). The concentration of CSF MBP was higher in dogs with an unsuccessful outcome compared with the healthy controls (P= .032). CSF MBP concentration was not significantly correlated with MFS at admission or CSF parameters. CSF MBP concentration did not vary over initial MFS categories within the successful outcome group (Table 2). CSF MBP concentration did not vary with initial MFS categories within the failure group (P= .548). The ROC curve analysis suggested an optimal CSF MBP cut-off value of 3 ng/mL (Fig 1). The sensitivity and specificity for predicting an unsuccessful outcome at this cutoff were 78 and 76%, respectively. Area under the ROC curve was estimated as 0.688 (95% confidence interval [CI] 0.445–0.930), but the overall ability of CSF MBP concentration in this analysis to predict successful long-term outcome was not significant (P= .079).

Table 1.   Myelin basic protein (MBP) concentrations measured in the cerebrospinal fluid (CSF) of 54 dogs with surgically confirmed intervertebral disk herniation (IVDH) and 16 healthy control dogs.
Factor (comparison)CSF MBP with FactorCSF MBP in Comparison GroupP-Valuea
nMedian (range)nMedian (range)
  • a

    Based on Mann-Whitney U-tests.

  • NSAID, nonsteroidal anti-inflammatory drugs; T2W, T2-weighted.

Affected (control)541.83 (0.54–72.6)162.22 (0–3.82).706
Successful outcome (not successful)421.53 (0.64–72.6)93.56 (0.54–51.2).081
Successful outcome (control)421.53 (0.64–72.6)162.22 (0–3.82).237
Not successful (control)93.56 (0.54–51.2)162.22 (0–3.82).032
Female (male)251.75 (0.54–24.0)291.85 (0.74–72.6).362
Intact (neutered)141.80 (0.74–72.6)401.83 (0.54–51.2).813
Age <5 years (age ≥5 years)231.43 (0.54–72.6)311.94 (0.64–48.8).441
Chondrodystrophic breed (other)491.75 (0.54–72.6)46.48 (1.43–9.20).071
Corticosteroids administered (not)151.75 (1.14–72.6)391.85 (0.54–51.2).582
NSAIDs administered (not)101.95 (1.06–24.0)431.85 (0.54–72.6).682
CSF pleocytosis (not)171.23 (0.54–51.2)371.94 (0.74–72.6).103
T2W hyperintensity (not)101.82 (0.87–24.0)141.77 (0.64–51.2).841
Table 2.   Myelin basic protein (MBP) concentration measured in the cerebrospinal fluid (CSF) of 51 dogs with surgically confirmed intervertebral disk herniation (IVDH) by initial modified Frankel score (MFS) and successful outcome from a single referral hospital in Texas during 2008.
Initial MFSSuccessFailureP-valuea
nMedian (range)nMedian (range)
  • a

    Based on Mann-Whitney U-tests comparing MBP between success and failure groups within MFS categories.

  • b

    Based on Mann-Whitney U-tests comparing MBP between success and failure groups within MFS categories (0–1 versus 2–3).

031.39 (1.04, 5.92)53.56 (0.54, 51.2).571
131.94 (1.43, 7.71)10.911.0
2141.51 (0.87, 72.6)15.251.0
3221.59 (0.64, 9.74)226.1 (3.49, 48.8).087
P-valueb .539 .548 

Figure 1.  Receiver-operating characteristic curve to predict successful outcome for myelin basic protein in the cerebrospinal fluid of 51 dogs with surgically confirmed intervertebral disk herniation from a single referral hospital in Texas. Sensitivity and specificity at 3.0 ng/mL were 78 and 76%, respectively, and designated by a triangle.

Download figure to PowerPoint

Both CSF MBP concentration and MFS at admission were significant predictors of long-term functional outcome (Table 3). Dogs with a CSF MBP concentration ≥3 ng/mL (cut-off identified by the ROC analysis) had 0.09 times the odds (95% CI 0.01–0.66) of long-term voluntary ambulation compared with dogs with CSF MBP concentration <3 ng/mL when adjusted for the effect of initial MFS (P= .018). The final multivariable model was a good fit to the data based on the Hosmer and Lemeshow test (χ2= 1.49, df= 4, P= .828). The exclusion of noncondrodystrophic dogs did not change qualitative results of the logistic models (data not shown).

Table 3.   Utility of myelin basic protein (MBP) in the cerebrospinal fluid (CSF) of 51 dogs with surgically confirmed intervertebral herniation (IVDH) to predict successful outcome after adjusting for severity of disease via the modified Frankel score (MFS) at admission.
VariableParameter Estimate (inline image)P-Value (Wald)Odds Ratio (95% CI)
MBP ≥3.0 ng/mL (versus <3)− 2.39.0180.09 (0.01, 0.66)
Initial MFS .006 
 MFS 0–1 (referent)  1.0
 MFS 22.63.04313.9 (1.08, 179)
 MFS 32.56.01712.9 (1.57, 105)


  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Footnotes
  7. Acknowledgments
  8. References

The results of the present study indicate that in dogs with thoracolumbar IVDH, CSF MBP concentration was associated with long-term functional outcome. A CSF MBP concentration of 3 ng/mL or greater had a sensitivity of 78% and specificity of 76% to predict an unsuccessful outcome based on the ROC analysis. A multivariable logistic regression was utilized to adjust for confounding by variables including MFS. In that model, dogs with CSF MBP ≥3 ng/mL had 0.09 times the odds of recovery compared with dogs with CSF MBP <3 ng/mL (95% CI 0.01–0.66, P= .018). Although CSF MBP has not been investigated previously in naturally occurring SCI, data from human traumatic brain injury and rodent models of SCI are consistent with these results.12,30,31

In rodent spinal cord contusion models, demyelination is initiated almost immediately after SCI, but can occur for months after injury because of autoimmune events and Wallerian degeneration.32 In dogs and humans with naturally occurring SCI, myelin destruction may be severe hours after primary events.33,34 As the persistence of functional white matter tracts is essential to limb function caudal to a lesion site, relationships between outcome and measures of myelinated axons are expected.35,36 For example, in histological spinal cord samples from injury models, loss of immunostaining for MBP is associated with contusion severity and physical examination-based determinants of recovery.19 Not only might high CSF MBP concentrations act as a surrogate measure for active demyelination, but MBP has been shown to exacerbate immunological secondary SCI. Rodents with experimental SCI that have been exposed to MBP exhibit enhanced rubrospinal tract loss, increased intralesional T-cell accumulation, and poorer locomotion compared with control animals.20

The independence of CSF MBP from initial MFS in dogs with thoracolumbar IVDH is important, especially considering the association between MFS and outcome. Physical examination-based SCI scales like the MFS are commonly used to characterize lesion severity, monitor recovery, and determine prognosis after injury. In the study reported here, dogs with an initial MFS of 2 had 13.9 times the odds of long-term ambulation compared with those dogs with an initial MFS of 0–1 (95% CI 1.08–179, P= .047). Yet, SCI scores have limitations. For example, scores do not inform observers about the mechanisms underlying a particular SCI and are imperfect at discerning structural versus functional lesions. It appears that regardless of MFS group, increased CSF MBP concentration is an indicator of poor functional outcome (Tables 2 and 3). This may suggest that either demyelination associated with CSF MBP release or secondary injury resulting from MBP have negative consequences in dogs with SCI resulting from thoracolumbar IVDH.

CSF MBP concentration was likewise not correlated to MRI-based markers of SCI in the study reported here. The lack of association with spinal cord T2W hyperintensity (Table 1) is not entirely surprising as high T2 signal after SCI may occur as a result of various pathological processes, including edema, necrosis, and hemorrhage.37,38 Additionally, the relatively low-field strength (1.0 T) of the MR in this report may have prohibited the detection of some lesions associated with demyelination on T2W images.39,40 Finally, only 24/54 dogs with IVDH had MRI performed, which likely limited our ability to detect associations.

In this report, the concentration of CSF MBP did not differ significantly between controls and dogs with thoracolumbar IVDH. Although, dogs with unsuccessful outcomes did have significantly higher CSF MBP concentration compared with unaffected control dogs. In humans with traumatic brain injury, the sensitivity of CSF MBP to detect injury was only 36%, which suggests significant overlap between concentrations in cases and controls in that group of patients.30 Dogs with degenerative myelopathy and control dogs did not have significant differences in cisternal CSF MBP concentration, although dogs with degenerative myelopathy did have higher CSF MBP concentration compared with controls when samples from the lumbar cistern were analyzed.18 Sample size and the site of CSF collection may have contributed to the lack of statistical significance for some comparisons. Differences in breed distribution and chondrodystrophoid status between the control and affected populations also may have influenced measured associations.

The lack of significance in the comparison of CSF MBP concentration between successful and unsuccessful outcome groups is different than the logistic regression results suggesting that CSF MBP concentration is a significant predictor of outcome. This contradiction is related to the designation of variables as predictors and outcomes in the statistical techniques. The comparison of CSF MBP concentration across outcome groups is beneficial as a descriptive technique, but from an analytic standpoint this comparison treats ambulatory outcome as a predictor of CSF MBP concentration. Logistic regression allows assessment of CSF MBP concentration as a predictor of ambulatory outcome and additionally controls for potential confounding variables. Therefore, it has an advantage over comparison of CSF MBP concentrations when ambulatory outcome prediction is the goal of an analysis. In the present study, discordant results were observed because the variability in CSF MBP concentration was high relative to the sample size. A larger sample size might have prevented this situation from occurring.

It is important to note that while CSF MBP is predictive of long-term functional outcome in dogs with thoracolumbar IVDH, cut-off values reported in this study are imperfect for determining outcome. For example, if the CSF MBP cutoff were applied to a population of 100 dogs with 25 unsuccessful outcomes, 6 dogs that ultimately failed to ambulate would be incorrectly assessed as having a good prognosis and 18 dogs that ultimately ambulated would be initially classified as having a poor prognosis. In the authors' view, CSF MBP should be thought of as an additional, independent prognostic indicator that can be used in combination with other assessment tools.

The major limitations of this study included the available sample size, single follow-up interval, and single center design. Although our sample size was similar to other biomarker studies on veterinary41–44 and human45–47 neurological diseases, a larger population could have enhanced the detection of differences between groups and improved the precision in reported associations. Specifically, the low number of unsuccessful outcomes (9/51) in this study reduced the power of statistical tests to evaluate predictors. The follow-up interval used in this report was based on data suggesting that the majority of dogs that voluntarily ambulate after surgical thoracolumbar IVDH do so within 3 months of SCI.5,48 Multiple intermediate follow-up intervals could have been utilized to detect differences in functional progression in the subacute phases of SCI between CSF MBP groups. Finally, the data in this report were generated at a single institution. A multicenter approach might have helped confirm these single center data, reduce potential confounders, and enhance study population.

A limited number of outcome determinants are known in dogs with acute thoracolumbar IVDH. These predictors are not absolute and the success proportion may be high even in the most severe injury groups. For example, voluntary ambulation occurs in 43–62% of dogs lacking pelvic limb deep nociception before surgery for thoracolumbar IVDH.5,8,49 Data from the study reported here suggest that substratification of outcome groups might be achieved using CSF MBP as the presence of high CSF MBP concentration was associated with poor long-term outcome regardless of MFS. Group stratification may assist in the early recognition of dogs that are in positive outcome categories based on MRI findings or MFS, but may be at risk for limited functional recovery. Additionally, based on the relationships detected in this report and experimental data to suggest a role for MBP in secondary SCI, future studies investigating targeted therapies may be warranted.


  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Footnotes
  7. Acknowledgments
  8. References

aRapinovet, Schering-Plough Animal Health Corp, Union, NJ

bSevoFlo, Abbott Laboratories, North Chicago, IL

cIsoFlo, Abbott Laboratories

dDell 1905 FP, Dell Corporation, Round Rock, TX

eeFilm 2.1 Veterinary, MERGE Healthcare, Cleveland, OH

fActive MBP ELISA, Diagnostic Systems Laboratories Inc, Webster, TX

gSPSS version 15.0 for Windows, SPSS Inc, Chicago, IL


  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Footnotes
  7. Acknowledgments
  8. References

The authors acknowledge Julie Harris, RVT; Alisha Onkst; and Amanda Garner, RVT for their help with data collection.

Source of funding: American Kennel Club ACORN grant #1180-A.


  1. Top of page
  2. Abstract
  3. Materials and Methods
  4. Results
  5. Discussion
  6. Footnotes
  7. Acknowledgments
  8. References
  • 1
    Hoerlein BF. Canine Neurology: Diagnosis and Treatment. Philadelphia, PA: WB Saunders; 1978.
  • 2
    Griffiths IR. Some aspects of the pathology and pathogenesis of the myelopathy caused by disc protrusions in dogs. J Neurol Neurosurg Psychiatry 1972;35:403413.
  • 3
    Hansen H. A pathologic-anatomical study on disc degeneration in the dog. Acta Orthop Scand 1952;11 (Suppl):1117.
  • 4
    Wright F, Palmer AC. Morphologic changes caused by pressure on the spinal cord. Pathol Vet 1969;6:355368.
  • 5
    Olby N, Levine J, Harris T, et al. Long-term functional outcome of dogs with severe injuries of the thoracolumbar spinal cord: 87 cases (1996–2001). J Am Vet Med Assoc 2003;222:762769.
  • 6
    Ruddle TL, Barnhart MD, Klocke NW, et al. Outcome and prognostic factors in non-ambulatory Hansen Type I intervertebral disc extrusions: 308 cases. Vet Comp Orthop Traumatol 2006;19:2934.
  • 7
    Scott HW, McKee WM. Laminectomy for 34 dogs with thoracolumbar intervertebral disc disease and loss of deep pain perception. J Small Anim Pract 1999;40:417422.
  • 8
    Ito D, Matsunaga S, Jeffrey ND, et al. Prognostic value of magnetic resonance imaging in dogs with paraplegia caused by thoracolumbar intervertebral disk extrusion: 77 cases (2000–2003). J Am Vet Med Assoc 2005;227:14541460.
  • 9
    Levine JM, Fosgate GT, Chen AV, et al. Magnetic resonance imaging findings associated with neurologic impairment in dogs with acute thoracic and lumbar intervertebral disk herniation. J Vet Intern Med 2009;23:12201226.
  • 10
    Morell P, Quarles RH, Norton WT. Formation, structure and biochemistry of myelin. In: SiegelG, AgranoffB, AlbersRW, MolinoffP, eds. Basic Neurochemistry. New York: Raven Press; 1989:109136.
  • 11
    Whitaker JN. Myelin basic protein in cerebrospinal fluid and other body fluids. Mult Scler 1998;4:1621.
  • 12
    Mukherjee A, Vogt RF, Linthicum DS. Measurement of myelin basic protein by radioimmunoassay in closed head trauma, multiple sclerosis, and other neurological diseases. Clin Biochem 1985;18:304307.
  • 13
    Barkhof F, Frequin ST, Hommes OR, et al. A correlative triad of gadolinium-DTPA MRI, EDSS, and CSF-MBP in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone. Neurology 1992;42:6367.
  • 14
    Thomson AJ, Brazil J, Feighery C, et al. CSF myelin basic protein in multiple sclerosis. Acta Neurol Scand 1985;72:577583.
  • 15
    Hergenroeder GW, Redell JB, Moore AN, et al. Biomarkers in the clinical diagnosis and management of traumatic brain injury. Mol Diagn Ther 2008;12:345358.
  • 16
    Lim ET, Grant D, Pashenkov M, et al. Cerebrospinal fluid levels of brain specific proteins in optic neuritis. Mult Scler 2004;10:261265.
  • 17
    Summers BA, Whitaker JN, Appel MJ. Demyelinating canine distemper encephalomyelitis: Measurement of myelin basic protein in cerebrospinal fluid. J Neuroimmunol 1987;14:227233.
  • 18
    Oji T, Kamishina H, Cheeseman JA, et al. Measurement of myelin basic protein in the cerebrospinal fluid of dogs with degenerative myelopathy. Vet Clin Pathol 2007;36:281284.
  • 19
    Nishi RA, Liu H, Chu Y, et al. Behavioral, histological, and ex vivo magnetic resonance imaging assessment of graded contusion spinal cord injury in mice. J Neurotrauma 2007;24:674689.
  • 20
    Jones TB, Ankeny DP, Guan Z, et al. Passive or active immunization with myelin basic protein impairs neurological function and exacerbates neuropathology after spinal cord injury in rats. J Neurosci 2004;24:37523761.
  • 21
    Jones TB, Basso DM, Sodhi A, et al. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: Implications for autoimmune vaccine therapy. J Neurosci 2002;22:26902700.
  • 22
    Witsberger TH, Levine JM, Slater MR, et al. Cerebrospinal fluid analysis and neurologic outcome at discharge after surgical treatment of intervertebral disc disease. Vet Surg 2009;38:E49.
  • 23
    Braund KG, Ghosh P, Taylor TK, et al. Morphological studies of the canine intervertebral disc. The assignment of the beagle to the achondroplastic classification. Res Vet Sci 1975;19:167172.
  • 24
    Martinez S, Fajardo R, Valdes J, et al. Histopathologic study of long-bone growth plates confirms the Basset Hound as an osteochondrodysplastic breed. Can J Vet Res 2007;71:6669.
  • 25
    Martinez S, Valdes J, Alonso RA. Achondroplastic dog breeds have no mutations in the transmembrane domain of the FGFR-3 gene. Can J Vet Res 2000;64:6669.
  • 26
    Willis M. Inheritance of specific skeletal and structural defects. In: WillisM, ed. Genetics of the Dog. UK: Howell Book House; 1989:119120.
  • 27
    Levine GJ, Levine JM, Budke CM, et al. Description and repeatability of a newly developed spinal cord injury scale for dogs. Prev Vet Med 2009;89:121127.
  • 28
    Hurtt AE, Smith MO. Effects of iatrogenic blood contamination on results of cerebrospinal fluid analysis in clinically normal dogs and dogs with neurologic disease. J Am Vet Med Assoc 1997;211:866867.
  • 29
    Windsor RC, Vernau KM, Sturges BK, et al. Lumbar cerebrospinal fluid in dogs with type I intervertebral disc herniation. J Vet Intern Med 2008;22:954960.
  • 30
    Berger RP, Dulani T, Adelson PD, et al. Identification of inflicted traumatic brain injury in well-appearing infants using serum and cerebrospinal markers: A possible screening tool. Pediatrics 2006;117:325332.
  • 31
    Kozlowski P, Raj D, Lie J, et al. Characterizing white matter damage in rat spinal cord with quantitative MRI and histology. J Neurotrauma 2008;25:653676.
  • 32
    Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2007;209:378388.
  • 33
    Smith PM, Jeffery ND. Histological and ultrastructural analysis of white matter damage after naturally-occurring spinal cord injury. Brain Pathol 2006;16:99109.
  • 34
    Totoiu MO, Keirstead HS. Spinal cord injury is accompanied by chronic progressive demyelination. J Comp Neurol 2005;486:373383.
  • 35
    Blight AR, Decrescito V. Morphometric analysis of experimental spinal cord injury in the cat: The relation of injury intensity to survival of myelinated axons. Neuroscience 1986;19:321341.
  • 36
    Bunge RP, Puckett WR, Becerra JL, et al. Observations on the pathology of human spinal cord injury. A review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv Neurol 1993;59:7589.
  • 37
    Hackney DB, Finkelstein SD, Hand CM, et al. Postmortem magnetic resonance imaging of experimental spinal cord injury: Magnetic resonance findings versus in vivo functional deficit. Neurosurgery 1994;35:11041111.
  • 38
    Duncan EG, Lemaire C, Armstrong RL, et al. High-resolution magnetic resonance imaging of experimental spinal cord injury in the rat. Neurosurgery 1992;31:510517; discussion 517–519.
  • 39
    Ertl-Wagner BB, Reith W, Sartor K. Low field-low cost: Can low-field magnetic resonance systems replace high-field magnetic resonance systems in the diagnostic assessment of multiple sclerosis patients? Eur Radiol 2001;11:14901494.
  • 40
    Phal PM, Usmanov A, Nesbit GM, et al. Qualitative comparison of 3-T and 1.5-T MRI in the evaluation of epilepsy. AJR Am J Roentgenol 2008;191:890895.
  • 41
    Levine JM, Ruaux CG, Bergman RL, et al. Matrix metalloproteinase-9 activity in the cerebrospinal fluid and serum of dogs with acute spinal cord trauma from intervertebral disk disease. Am J Vet Res 2006;67:283287.
  • 42
    Sullivan LA, Campbell VL, Klopp LS, et al. Blood lactate concentrations in anesthetized dogs with intracranial disease. J Vet Intern Med 2009;23:488492.
  • 43
    Bathen-Noethen A, Carlson R, Menzel D, et al. Concentrations of acute-phase proteins in dogs with steroid responsive meningitis-arteritis. J Vet Intern Med 2008;22:11491156.
  • 44
    Lowrie M, Penderis J, McLaughlin M, et al. Steroid responsive meningitis-arteritis: A prospective study of potential disease markers, prednisolone treatment, and long-term outcome in 20 dogs (2006–2008). J Vet Intern Med 2009;23:862870.
  • 45
    Breers SR, Berger RP, Adelson PD. Neurocognitive outcome and serum biomarkers in inflicted versus non-inflicted traumatic brain injury in young children. J Neurotrauma 2007;24:97105.
  • 46
    Brisby H, Olmarker K, Rosengren L, et al. Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica. Spine 1999;24:742746.
  • 47
    Guez M, Hildingsson C, Rosengren L, et al. Nervous tissue damage markers in cerebrospinal fluid after cervical spine injuries and whiplash trauma. J Neurotrauma 2003;20:853858.
  • 48
    Olby N, Harris T, Burr J, et al. Recovery of pelvic limb function in dogs following acute intervertebral disc herniations. J Neurotrauma 2004;21:4959.
  • 49
    Duval J, Dewey C, Roberts R, et al. Spinal cord swelling as a myelographic indicator of prognosis: A retrospective study in dogs with intervertebral disc disease and loss of deep pain perception. Vet Surg 1996;25:612.